Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome

ClinicalTrials.gov ID: NCT03806127

Public ClinicalTrials.gov record NCT03806127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain associated with irritable bowel syndrome (IBS) due to IBS with predominant diarrhea (IBS-D) or mixed episodes of diarrhea and constipation (IBS-M).

Study identification

NCT ID
NCT03806127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Urovant Sciences GmbH
Industry
Enrollment
222 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 30, 2018
Primary completion
Sep 24, 2020
Completion
Oct 5, 2020
Last update posted
Aug 1, 2021

2018 – 2020

United States locations

U.S. sites
41
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Synexus Clinical Research US, Inc.-Simon Williamson Clinic Birmingham Alabama 35211
Clinical Research Associates Huntsville Alabama 35801
Alabama Medical Group, PC Mobile Alabama 36693
Hope Research Institute Chandler Arizona 85224
Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC Chandler Arizona 85224
Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC Mesa Arizona 85206
Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC Mesa Arizona 85213
Synexus - Clinical Research Advantage, Inc. - Central Phoenix Medical Clinic LLC Phoenix Arizona 85020
GW Research Inc - ClinEdge-PPDS Chula Vista California 91910
Triwest Research Associates, LLC La Mesa California 91942
VA Long Beach Healthcare System - NAVREF Long Beach California 90822
Southern California Research Institute Medical Group, Inc. Los Angeles California 90045
Desta Digestive Disease Medical Center San Diego California 92114
Medical Associates Research Group, Inc. San Diego California 92123
Torrance Clinical Research Torrance California 90505
Medical Research Center of Connecticut LLC Hamden Connecticut 06518
Mayo Clinic - Division of Gastroenterology Jacksonville Florida 32224
Florida Center For Gastroenterology Largo Florida 33777
Clinical Research Center of Florida Pompano Beach Florida 33060
Palm Beach Research - ClinEdge - PPDS West Palm Beach Florida 33409
RNA America, LLC Sugar Hill Georgia 30518
Investigators Research Group, LLC Indianapolis Indiana 46268
Mandeville Private Physician Group, LLC Mandeville Louisiana 70471
Massachusetts General Hospital Boston Massachusetts 02114
University of Michigan Ann Arbor Michigan 48109
Clinical Research Institute of Michigan Chesterfield Michigan 48047
Synexus Clinical Research US, Inc. - Rita B. Chuang, MD, LLC Henderson Nevada 89502
Advanced Research Institute Reno Nevada 89511
Atrium Healthcare Center for Digestive Health Charlotte North Carolina 28204
Carolina Digestive Diseases Greenville North Carolina 27834
East Carolina Gastroenterology Jacksonville North Carolina 28546
Dayton Gastroenterology, Inc. Beavercreek Ohio 45440
Central Sooner Research Norman Oklahoma 73071
Synexus Clinical Research US, Inc. - Anderson Anderson South Carolina 29621
Chattanooga Medical Research Inc Chattanooga Tennessee 37404
Clinical Research Solutions PC Jackson Tennessee 38305
DHAT Research Institute Garland Texas 75044
University of Texas Health Science Center at Houston Houston Texas 77030
Synexus Clinical Research US, Inc.-Plano Plano Texas 75093
Synexus Clinical Research US, Inc. - Wasatch Peak Family Practice Layton Utah 84041
Advanced Research Institute South Ogden Utah 84405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03806127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2021 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03806127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →